Related Experiment Videos
Staging in childhood lymphoma: differences between FDG-PET and CT
S Hermann1, D Wormanns, M Pixberg
1Department of Nuclear Medicine, University Hospital Münster, Albert-Schweitzer-Str. 33, 48149 Münster, Germany. shermann@uni-muenster.de
Nuklearmedizin. Nuclear Medicine
|February 16, 2005
Summary
Positron emission tomography (PET) staging for childhood lymphoma differs from computed tomography (CT) in 6 of 25 patients. Further research is needed to understand how these differences impact pediatric lymphoma treatment.
Area of Science:
- Nuclear Medicine
- Pediatric Oncology
- Radiology
Background:
- Fluorine-18 fluoro-deoxy-glucose positron emission tomography (FDG-PET) is established for adult lymphoma staging.
- Limited data exist on FDG-PET's utility in pediatric lymphoma staging.
Purpose of the Study:
- To compare the accuracy of FDG-PET with computed tomography (CT) for staging childhood lymphoma.
- To evaluate discrepancies in staging between FDG-PET and CT in pediatric patients.
Main Methods:
- Retrospective analysis of 25 children with Hodgkin's or non-Hodgkin's lymphoma.
- Whole-body FDG-PET and CT imaging were performed and independently assessed by two physicians.
- 30 regions (nodal and extranodal) per patient were evaluated using a five-value scale.
Main Results:
- FDG-PET and CT showed concordant findings in 92% of assessed regions.
- Discordant findings occurred in 7% of regions, with FDG-PET identifying more positive sites in some cases and CT in others.
- FDG-PET resulted in upstaging in 4 patients and downstaging in 2 patients compared to CT.
Conclusions:
- FDG-PET staging for childhood lymphoma revealed differences compared to CT, altering the stage in 6 out of 25 patients.
- Prospective studies are necessary to determine the clinical significance of these staging discrepancies in pediatric lymphoma management.